Skip to content

THRIVE Use in Pediatric Populations- Multi Site

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Populations: A Randomized Prospective Multi-Site Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04322994
Enrollment
175
Registered
2020-03-26
Start date
2020-10-21
Completion date
2024-01-19
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia; Adverse Effect, Desaturation of Blood, Hypoventilation, Oxygen Deficiency

Brief summary

THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can prevent desaturation events in children under anesthesia and improve the outcomes of that surgery.

Interventions

DEVICETransnasal Humidified Rapid-Insufflation Ventilatory Echange

The use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia.

Sponsors

Nationwide Children's Hospital
CollaboratorOTHER
Ann & Robert H Lurie Children's Hospital of Chicago
CollaboratorOTHER
Boston Children's Hospital
CollaboratorOTHER
UC Davis Children's Hospital
CollaboratorUNKNOWN
Stanford University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Pediatric patients less than 18 years of age undergoing general anesthesia for procedures or surgeries

Exclusion criteria

* Pregnancy * Absence of parent or legal guardian able to provide written consent for study participation * Anatomical or surgical contraindications (epistaxis, basilar skull fractures or abnormalities, nasal surgery or obstruction, nasal fractures, nasal vascular abnormalities), tracheostomy tube * Emergent surgery for which application of HFNC might delay surgery or might result in increased aspiration risk.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With 4% Decrease From Baseline in Oxygen Desaturation IndexDuration of surgery or procedure, which is generally less than 2 hoursOxygen desaturation index is defined as a 4% decrease in saturation from a 120 second rolling mean for greater than 10 seconds; data were recorded every 2 seconds while the procedure was being performed.
Number of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline SaturationDuration of surgery or procedure, which is generally less than 2 hoursRelative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed. Participants who experienced both a fall below 90% O2 and a 4% drop below baseline saturation are reported as having more than 1 event.
Number of Participants With Desaturations <90%Duration of surgery or procedure, which is generally less than 2 hoursRelative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed.

Secondary

MeasureTime frameDescription
Time-normalized Area Under Curve (AUC) of Desaturations <90%Duration of surgery or procedure, which is generally less than 2 hoursDuration of oxygen desaturation less than 90% as measured by pulse oximetry by second by analyzing area under curve less than 90% (in those participants who experienced desaturation less than 90%), normalized as area under the curve / total time.
Number of Participants With Surgical Interruptions Due to DesaturationDuration of surgery or procedure, which is generally less than 2 hoursNumber of surgical interruptions due to desaturation defined by a pause in surgical procedures due to need to provide airway intervention to improve patient's oxygen saturation, normalized to case length. Airway interventions may include jaw thrust, bag mask ventilation, and/or endotracheal intubations.
Minimum Oxygen Saturation as a Measure of Desaturation SeverityDuration of surgery or procedure by second, which is generally less than 2 hoursNumber of participants categorized by lowest oxygen saturation level during surgery (nadir). Lower saturation levels correspond to a lower level of oxygen in red blood cells.

Other

MeasureTime frameDescription
Sinus Pressure / PainEvaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperativelyIncidence of sinus pressure and/or pain as measured by post-operative survey
Nasal IrritationEvaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperativelyIncidence of nasal irritation as measured by post-operative survey
HeadacheEvaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperativelyIncidence of headache as measured by post-operative survey
Other Adverse EventsEvaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperativelyOther adverse events as measured by post-operative survey
Gas Pain or BloatingEvaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperativelyIncidence of gas pain or bloating as measured by post-operative survey

Countries

United States

Participant flow

Recruitment details

Participants were recruited from six pediatric sites (Lucile Packard Children's Hospital, Cincinnati Children's hospital, Lurie Children's Hospital, University of Virginia Children's Hospital, Massachusetts Eye and Ear Infirmary, and Boston Children's Hospital between October 2020 and January 2024. The first participant was enrolled on October 21, 2020 and the last participant was enrolled in January 19, 2024.

Participants by arm

ArmCount
Control
Participants undergo their scheduled procedure and recovery with the usual care.
71
High-flow Nasal Cannula
Participants undergo their scheduled procedure, and also have a high-flow nasal cannula applied prior to the start of the procedure and removed following the procedure's conclusion.
73
Total144

Baseline characteristics

CharacteristicControlHigh-flow Nasal CannulaTotal
Age, Continuous5.6 years
STANDARD_DEVIATION 5.2
4.7 years
STANDARD_DEVIATION 5.1
5.1 years
STANDARD_DEVIATION 5.1
Race/Ethnicity, Customized
Asian
5 Participants2 Participants7 Participants
Race/Ethnicity, Customized
Black
1 Participants2 Participants3 Participants
Race/Ethnicity, Customized
Hispanic
13 Participants18 Participants31 Participants
Race/Ethnicity, Customized
Missing
6 Participants4 Participants10 Participants
Race/Ethnicity, Customized
Multirace
2 Participants4 Participants6 Participants
Race/Ethnicity, Customized
White
44 Participants43 Participants87 Participants
Region of Enrollment
United States
71 Participants73 Participants144 Participants
Sex: Female, Male
Female
28 Participants20 Participants48 Participants
Sex: Female, Male
Male
43 Participants53 Participants96 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 880 / 87
other
Total, other adverse events
0 / 880 / 87
serious
Total, serious adverse events
0 / 880 / 87

Outcome results

Primary

Number of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation

Relative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed. Participants who experienced both a fall below 90% O2 and a 4% drop below baseline saturation are reported as having more than 1 event.

Time frame: Duration of surgery or procedure, which is generally less than 2 hours

Population: Participants who completed the protocol.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline SaturationAny event19 Participants
ControlNumber of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation1 event3 Participants
ControlNumber of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation2+ events16 Participants
High-flow Nasal CannulaNumber of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline SaturationAny event13 Participants
High-flow Nasal CannulaNumber of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation1 event3 Participants
High-flow Nasal CannulaNumber of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation2+ events10 Participants
Comparison: Analysis of between-group difference for participants with any qualifying event.p-value: 0.28Chi-squared
Comparison: Analysis of between-group difference for participants with 1 qualifying event versus 2 or more events.p-value: 0.38Chi-squared
Primary

Number of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index

Oxygen desaturation index is defined as a 4% decrease in saturation from a 120 second rolling mean for greater than 10 seconds; data were recorded every 2 seconds while the procedure was being performed.

Time frame: Duration of surgery or procedure, which is generally less than 2 hours

Population: Participants who completed the protocol.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants With 4% Decrease From Baseline in Oxygen Desaturation IndexAny event18 Participants
ControlNumber of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index1 event13 Participants
ControlNumber of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index2+ events5 Participants
High-flow Nasal CannulaNumber of Participants With 4% Decrease From Baseline in Oxygen Desaturation IndexAny event11 Participants
High-flow Nasal CannulaNumber of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index1 event9 Participants
High-flow Nasal CannulaNumber of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index2+ events2 Participants
Comparison: Analysis of between-group difference for participants with any desaturation event.p-value: 0.18Chi-squared
Comparison: Analysis of between-group difference for participants with 1 desaturation event versus 2 or more events.p-value: 0.26Chi-squared
Primary

Number of Participants With Desaturations <90%

Relative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed.

Time frame: Duration of surgery or procedure, which is generally less than 2 hours

Population: Participants who completed the protocol.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants With Desaturations <90%Any event17 Participants
ControlNumber of Participants With Desaturations <90%1 event8 Participants
ControlNumber of Participants With Desaturations <90%2+ events9 Participants
High-flow Nasal CannulaNumber of Participants With Desaturations <90%Any event11 Participants
High-flow Nasal CannulaNumber of Participants With Desaturations <90%1 event9 Participants
High-flow Nasal CannulaNumber of Participants With Desaturations <90%2+ events2 Participants
Comparison: Analysis of between-group difference for participants with at any qualifying desaturation event.p-value: 0.26Chi-squared
Comparison: Analysis of between-group difference for participants with 1 qualifying desaturation event versus 2 or more qualifying events.p-value: 0.08Chi-squared
Secondary

Minimum Oxygen Saturation as a Measure of Desaturation Severity

Number of participants categorized by lowest oxygen saturation level during surgery (nadir). Lower saturation levels correspond to a lower level of oxygen in red blood cells.

Time frame: Duration of surgery or procedure by second, which is generally less than 2 hours

Population: Participants who completed the protocol.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlMinimum Oxygen Saturation as a Measure of Desaturation Severity0-50% O2 saturation2 Participants
ControlMinimum Oxygen Saturation as a Measure of Desaturation Severity50-70% O2 saturation3 Participants
ControlMinimum Oxygen Saturation as a Measure of Desaturation Severity70-90% O2 saturation12 Participants
ControlMinimum Oxygen Saturation as a Measure of Desaturation Severity90-100% O2 saturation54 Participants
High-flow Nasal CannulaMinimum Oxygen Saturation as a Measure of Desaturation Severity90-100% O2 saturation62 Participants
High-flow Nasal CannulaMinimum Oxygen Saturation as a Measure of Desaturation Severity0-50% O2 saturation2 Participants
High-flow Nasal CannulaMinimum Oxygen Saturation as a Measure of Desaturation Severity70-90% O2 saturation7 Participants
High-flow Nasal CannulaMinimum Oxygen Saturation as a Measure of Desaturation Severity50-70% O2 saturation2 Participants
Secondary

Number of Participants With Surgical Interruptions Due to Desaturation

Number of surgical interruptions due to desaturation defined by a pause in surgical procedures due to need to provide airway intervention to improve patient's oxygen saturation, normalized to case length. Airway interventions may include jaw thrust, bag mask ventilation, and/or endotracheal intubations.

Time frame: Duration of surgery or procedure, which is generally less than 2 hours

Population: Participants who completed the protocol.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ControlNumber of Participants With Surgical Interruptions Due to DesaturationAny event14 Participants
ControlNumber of Participants With Surgical Interruptions Due to Desaturation1 event11 Participants
ControlNumber of Participants With Surgical Interruptions Due to Desaturation2+ events3 Participants
High-flow Nasal CannulaNumber of Participants With Surgical Interruptions Due to DesaturationAny event7 Participants
High-flow Nasal CannulaNumber of Participants With Surgical Interruptions Due to Desaturation1 event5 Participants
High-flow Nasal CannulaNumber of Participants With Surgical Interruptions Due to Desaturation2+ events2 Participants
Comparison: Analysis of between-group difference for participants with any surgical interruption.p-value: 0.14Chi-squared, Corrected
Comparison: Analysis of between-group difference for participants with 1 surgical interruption versus 2 or more interruptions.p-value: 0.21Chi-squared
Secondary

Time-normalized Area Under Curve (AUC) of Desaturations <90%

Duration of oxygen desaturation less than 90% as measured by pulse oximetry by second by analyzing area under curve less than 90% (in those participants who experienced desaturation less than 90%), normalized as area under the curve / total time.

Time frame: Duration of surgery or procedure, which is generally less than 2 hours

Population: Participants who experienced desaturation less than 90%

ArmMeasureValue (MEAN)Dispersion
ControlTime-normalized Area Under Curve (AUC) of Desaturations <90%0.3 % of blood oxygen saturationStandard Error 0.91
High-flow Nasal CannulaTime-normalized Area Under Curve (AUC) of Desaturations <90%0.28 % of blood oxygen saturationStandard Error 1.19
Comparison: Analysis of between-group difference for participants with at any qualifying desaturation event.p-value: 0.88t-test, 2 sided
Other Pre-specified

Gas Pain or Bloating

Incidence of gas pain or bloating as measured by post-operative survey

Time frame: Evaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperatively

Other Pre-specified

Headache

Incidence of headache as measured by post-operative survey

Time frame: Evaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperatively

Other Pre-specified

Nasal Irritation

Incidence of nasal irritation as measured by post-operative survey

Time frame: Evaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperatively

Other Pre-specified

Other Adverse Events

Other adverse events as measured by post-operative survey

Time frame: Evaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperatively

Other Pre-specified

Sinus Pressure / Pain

Incidence of sinus pressure and/or pain as measured by post-operative survey

Time frame: Evaluated postoperatively in post-anesthesia recovery unit prior to discharge, which is about 60 minutes postoperatively

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026